Your browser is no longer supported. Please, upgrade your browser.
Settings
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E22.13 EPS (ttm)3.54 Insider Own0.10% Shs Outstand1.48B Perf Week0.10%
Market Cap116.06B Forward P/E8.28 EPS next Y9.46 Insider Trans-4.28% Shs Float1.48B Perf Month-1.52%
Income5.42B PEG3.27 EPS next Q2.20 Inst Own70.80% Short Float1.33% Perf Quarter-3.18%
Sales32.65B P/S3.56 EPS this Y4.80% Inst Trans-1.80% Short Ratio3.82 Perf Half Y-8.60%
Book/sh-5.29 P/B- EPS next Y7.67% ROA8.70% Target Price90.07 Perf Year-21.41%
Cash/sh3.52 P/C22.20 EPS next 5Y6.78% ROE-94.50% 52W Range73.81 - 100.23 Perf YTD-15.12%
Dividend4.28 P/FCF16.25 EPS past 5Y7.60% ROI21.80% 52W High-21.93% Beta1.05
Dividend %5.47% Quick Ratio0.90 Sales past 5Y11.80% Gross Margin77.30% 52W Low6.02% ATR1.51
Employees30000 Current Ratio1.00 Sales Q/Q-1.30% Oper. Margin19.90% RSI (14)50.84 Volatility1.53% 1.83%
OptionableYes Debt/Eq- EPS Q/Q-5.10% Profit Margin16.30% Rel Volume1.05 Prev Close78.65
ShortableYes LT Debt/Eq- EarningsJul 25 BMO Payout113.20% Avg Volume5.14M Price78.25
Recom2.90 SMA20-0.18% SMA50-1.05% SMA200-7.33% Volume5,412,800 Change-0.51%
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Oct-02-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-25-17Downgrade UBS Buy → Neutral $79 → $92
Aug-17-17Initiated Evercore ISI Outperform $95
Jun-22-17Upgrade Societe Generale Hold → Buy
Mar-22-17Upgrade Societe Generale Sell → Hold
Oct-31-16Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Mkt Perform $70
Jun-17-19 06:13PM  Bayer to Invest 5 Billion Euros in Weedkiller Research Zacks
05:45PM  AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know Zacks
05:26PM  J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study Zacks
03:41PM  Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz Zacks
10:25AM  Top Ranked Income Stocks to Buy for June 17th Zacks
09:15AM  Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio Zacks
06:00AM  Why AbbVie Is a Retiree's Dream Stock Motley Fool
Jun-14-19 12:06PM  3 Big Pharma Stocks to Buy Right Now Zacks
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
08:24AM  Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study Zacks
Jun-12-19 06:00PM  New Long-Term Data from Upadacitinib Phase 3 Studies in Rheumatoid Arthritis Including Results on Clinical Remission at 48 Weeks Presented at EULAR PR Newswire
11:10AM  Top Marijuana Stocks That Pay Dividends Investopedia
08:15AM  5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit Motley Fool
Jun-11-19 03:15PM  10 Smart Dividend Stocks for the Rest of the Year InvestorPlace
09:54AM  Roche's Polivy Gets FDA Nod, Gazyva Meets Goals in Phase II Zacks
09:03AM  Lilly Announces Tradjenta Cardiovascular Outcome Study Data Zacks
07:00AM  New Two-Year Data at the 24th World Congress of Dermatology Shows SKYRIZI (risankizumab) Maintains Complete Skin Clearance PR Newswire
06:00AM  AbbVie- Unique Mix of Growth, Income Value MoneyShow
01:39AM  Horseman Capital Managements Return, AUM, and Holdings Insider Monkey
Jun-10-19 05:45PM  AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know Zacks
11:11AM  Top Ranked Growth Stocks to Buy for June 10th Zacks
08:00AM  AbbVie's MAVIRET now listed on the Nova Scotia and Manitoba formularies CNW Group
Jun-07-19 11:04AM  AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study Zacks
10:25AM  Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix Zacks
08:00AM  AbbVie to Present at the Goldman Sachs Global Healthcare Conference PR Newswire
07:45AM  Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far Motley Fool
Jun-06-19 06:02PM  Are Hedge Funds Going To Get Burned By AbbVie Inc (ABBV) ? Insider Monkey
09:00AM  AbbVie Receives Positive Recommendation from the pan-Canadian Oncology Drug Review Expert Review Committee for the Combination VENCLEXTA® With Rituximab as a Treatment for Patients With Chronic Lymphocytic Leukemia CNW Group
07:21AM  Top Ranked Income Stocks to Buy for June 6th Zacks
06:42AM  Bet on 5 Top Stocks With Rising P/E Zacks
Jun-05-19 04:55PM  101 Best Dividend Stocks to Buy for 2019 and Beyond Kiplinger
09:05AM  Pfizer to Launch Several Drugs Despite Generic Headwinds Zacks
Jun-04-19 11:09AM  AbbVie Presents Data from Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia PR Newswire
10:18AM  Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication Zacks
Jun-03-19 05:45PM  AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Zacks
Jun-01-19 10:17AM  Here is the 16th Most Popular Stock Among Hedge Funds Insider Monkey
May-31-19 09:15AM  Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio Zacks
08:25AM  Vertex Selects Triple Combo Regimen for Regulatory Submission Zacks
May-30-19 02:36PM  3 Top Gene Therapy Stocks That Could Soar InvestorPlace
09:45AM  The Inverted Yield Curve Should Make Investors Pivot, Not Panic InvestorPlace
08:45AM  AbbVie Presents Results from Several Studies and Clinical Trials Investigating Medicines Across More than 15 Cancers at the 2019 ASCO and EHA Meetings PR Newswire
08:00AM  AbbVie's MAVIRET now listed in New Brunswick CNW Group
May-28-19 05:22PM  Gilead Sciences Slips on Goldman's Downgrade to Sell TheStreet.com
09:25AM  J&J Stock Up This Year So Far: Will the Momentum Continue? Zacks
May-27-19 06:24PM  This 5% Dividend Yield Isn't Good Enough for Me Motley Fool
05:55AM  Glaxo's Shingles Vaccine Shingrix Gets Approval in China Zacks
May-25-19 09:31AM  Why Is AbbVie (ABBV) Up 0.9% Since Last Earnings Report? Zacks
May-24-19 03:58PM  The Blooming Weed Industry Explained In Charts And Maps: Storefronts And Deliveries By The Numbers Benzinga
09:30AM  Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates Zacks
May-23-19 09:00AM  AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for VENCLEXTA®, a treatment for chronic lymphocytic leukemia (CLL) CNW Group
08:20AM  J&J's Invokana sNDA Gets Priority Review Status From FDA Zacks
May-22-19 09:50AM  Lilly's Crohn's Disease Candidate Meets Phase II Study Goals Zacks
09:23AM  3 Top Dividend Stocks With Yields Over 5% Motley Fool
08:47AM  Top Ranked Income Stocks to Buy for May 22nd Zacks
07:19AM  Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead Zacks
May-21-19 09:00AM  Better Buy: AbbVie vs. Pfizer Motley Fool
08:00AM  AbbVie Launches ORILISSA (elagolix) 200 mg BID Dose for the Treatment of Moderate to Severe Pain Associated with Endometriosis CNW Group
07:47AM  Top Ranked Income Stocks to Buy for May 21st Zacks
07:15AM  3 Top Dividend Stocks to Buy Right Now Motley Fool
May-20-19 12:31PM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
09:02AM  AbbVie's Brain Cancer Candidate Fails in Phase III Study Zacks
May-19-19 07:00AM  Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big Motley Fool
May-17-19 05:19PM  Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL Zacks
09:19AM  AbbVie halts enrollment after brain cancer trial misses goal, shares fall Reuters
09:00AM  AbbVie halts patient enrollment after brain cancer trial misses goal Reuters
09:00AM  AbbVie stock down 1.8% in premarket trade after failure of glioblastoma drug trial MarketWatch
08:45AM  AbbVie Provides Update on Depatuxizumab Mafodotin (Depatux-M), an Investigational Medicine for Newly Diagnosed Glioblastoma, an Aggressive Form of Brain Cancer PR Newswire
08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
May-15-19 02:19PM  AbbVie Announces US FDA Approval of VENCLEXTA® (venetoclax) as a Chemotherapy-Free Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia Patients PR Newswire
09:15AM  Why AbbVie (ABBV) is a Great Dividend Stock Right Now Zacks
08:45AM  3 Reasons Why AbbVie (ABBV) Is a Great Growth Stock Zacks
07:46AM  AbbVie Settles Humira Litigation With Boehringer Ingelheim Zacks
12:57AM  PRESS DIGEST -Wall Street Journal - May 15 Reuters
May-14-19 10:43AM  AbbVie Rises 3% Investing.com
10:13AM  MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint® System Business Wire
10:07AM  Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman MarketWatch
08:57AM  AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S. MarketWatch
08:34AM  AbbVie Resolves HUMIRA® (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim PR Newswire
08:00AM  AbbVie to Present at the UBS Global Healthcare Conference PR Newswire
May-13-19 06:00AM  AbbVie- Unique Mix of Growth, Yield and Value MoneyShow
May-09-19 01:39PM  Parnassus Endeavor Fund Buys 2 Pharmaceutical Stocks in 1st Quarter GuruFocus.com
May-08-19 04:49PM  Parnassus Endeavor Fund Buys AbbVie, Boosts Biogen GuruFocus.com
07:47AM  Top Ranked Income Stocks to Buy for May 8th Zacks
May-07-19 08:00AM  AbbVie to Present at the Bank of America Merrill Lynch Healthcare Conference PR Newswire
May-06-19 09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
09:11AM  Top Ranked Income Stocks to Buy for May 6th Zacks
06:37AM  Two Healthcare Stocks in the XLV Fund Stand Out InvestorPlace
06:30AM  Alector Announces First Alzheimers Disease Patient Dosed in Phase 1b Study of AL002 GlobeNewswire
May-03-19 11:37AM  Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates Zacks
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
May-02-19 01:21PM  These 6 biotech stocks are promising takeover targets MarketWatch
May-01-19 06:56PM  The Top Pharma Stocks for 2019 Investopedia
01:55PM  Profit from Earnings Volatility With This Biotech Stocks Pairs Trade InvestorPlace
08:55AM  The Zacks Analyst Blog Highlights: Facebook, Comcast, AbbVie, Union Pacific and Air Products Zacks
Apr-30-19 02:52PM  Top Stock Reports for Facebook, Comcast & AbbVie Zacks
07:45AM  European Commission Approves SKYRIZI (risankizumab) for the Treatment of Moderate to Severe Plaque Psoriasis PR Newswire
07:08AM  AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting PR Newswire
Apr-29-19 05:08PM  Better Big Pharma Stock: AbbVie vs. AstraZeneca Motley Fool
09:15AM  Why AbbVie (ABBV) is a Great Dividend Stock Right Now Zacks
09:00AM  AbbVie (ABBV) Upgraded to Buy: Here's Why Zacks
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Durkin Brian LVP, ControllerMar 25Sale79.6947537,8539,121Mar 25 04:34 PM
Schumacher Laura JVice ChairmanMar 14Sale80.0025,0002,000,000139,838Mar 15 05:53 PM
SALEKI-GERHARDT AZITAEVP, OperationsMar 05Sale79.0315,7971,248,48093,312Mar 06 05:03 PM
Schumacher Laura JVice ChairmanDec 28Sale90.0025,0002,250,000134,322Jan 02 04:49 PM
CHASE WILLIAM JEVP, Finance & AdministrationDec 12Sale90.0060,0005,400,000104,863Dec 14 05:12 PM
GONZALEZ RICHARD AChairman of the Board and CEODec 11Sale88.7516,8501,495,438286,203Dec 13 04:56 PM
Schumacher Laura JExecutive Vice PresidentDec 04Option Exercise51.4294,1404,840,679192,398Dec 07 05:15 PM
Schumacher Laura JExecutive Vice PresidentDec 04Sale93.5894,1408,809,55298,258Dec 07 05:15 PM
Gosebruch Henry OEVP, Chief Strategy OfficerNov 29Sale90.1042,4503,824,94030,350Nov 30 05:22 PM
SEVERINO MICHAELEVP, R&D and CSOAug 17Sale97.5250,0004,876,06082,281Aug 21 04:58 PM
TILTON GLENN FDirectorJun 27Buy91.905,400496,27439,735Jun 29 02:30 PM
RAPP EDWARD JDirectorJun 20Buy98.631,01399,90920,743Jun 22 05:56 PM